ALZHEIMER'S TYPE DEMENTIA

Clinical trials for ALZHEIMER'S TYPE DEMENTIA explained in plain language.

Never miss a new study

Get alerted when new ALZHEIMER'S TYPE DEMENTIA trials appear

Sign up with your email to follow new studies for ALZHEIMER'S TYPE DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for calming Alzheimer's agitation

Symptom relief Recruiting now

This study is testing whether an experimental drug called masupirdine can safely reduce agitation in people with Alzheimer's dementia. About 375 participants will take either the drug or a placebo pill daily for 12 weeks. Researchers will measure changes in aggressive behaviors, …

Matched conditions: ALZHEIMER'S TYPE DEMENTIA

Phase: PHASE3 • Sponsor: Suven Life Sciences Limited • Aim: Symptom relief

Last updated Mar 31, 2026 12:12 UTC

ALZHEIMER'S TYPE DEMENTIA

Get alerted when new ALZHEIMER'S TYPE DEMENTIA trials appear

New hope for calming Alzheimer's agitation